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Introduction: Although non-Hodgkin’s lymphoma is one of the most common and frequently fatal of the
acquired immune deficiency syndrome-defining illnesses, survival has improved significantly since the introduction
of antiretroviral therapy. Patients with spinal cord compression resulting from non-Hodgkin’s lymphoma present with
clinically acute or rapidly progressive neurologic deficits. The purpose of this case report is to present a case of a patient
seropositive for human immunodeficiency virus with spinal cord compression due to B-cell lymphoma, unclassifiable,
with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma.
Case presentation: A 40-year-old Asian man, who was seropositive for human immunodeficiency virus, presented with
progressive neurological deficits. Magnetic resonance images of his thoracic spine showed an epidural mass from T2 to
T4, resulting in severe cord compression. Emergent surgical decompression and biopsy were performed, followed by
palliative radiation therapy. The pathologic findings showed that the specimen was compatible with B-cell lymphoma,
unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma. Palliative
radiation therapy was performed; however, leptomeningeal seeding and pulmonary embolism led to his death.
Conclusions: When a patient infected with human immunodeficiency virus presents with a rapidly progressive spinal
tumor accompanying paraplegia, non-Hodgkin’s lymphoma should be considered, and surgical decompression should
be weighed with respect to the patient’s general condition and the subtype/prognosis of the lymphoma.
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cord compressionIntroduction
The 2008 World Health Organization classification system
of tumors of hematopoietic and lymphoid tissue included
an overlap category termed B-cell lymphoma, unclassifi-
able (B-UCL), with features intermediate between diffuse
large B-cell lymphoma (DLBCL) and Burkitt lymphoma
(BL) [1]. Previously classified as Burkitt-like lymphomas,
this nonhomogeneous category encompasses several types* Correspondence: kyh@catholic.ac.kr
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diagnose due to the lack of specific morphologic, genetic
and immunophenotypic patterns. They do not respond to
BL- or DLBCL-type chemotherapeutic regimens, and no
treatment consensus in patients with B-UCL has been
determined [2]. We present a case of a patient with
spinal cord compression caused by an acquired immune
deficiency syndrome (AIDS)-related B-UCL with features
intermediate between DLBCL and BL.. This is an Open Access article distributed under the terms of the Creative
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iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 2 Computed tomography shows no bony destruction at
the T2 to T4 levels.
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A 40-year-old Asian man complained of progressive pain
and weakness in his lower extremities. A physical examin-
ation showed decreased muscle power (Frankel grade D),
increased sensory loss below the T6 dermatome, ankle
clonus and abnormal Babinski reflex. He was diagnosed as
being seropositive for human immunodeficiency virus
(HIV) 6 months ago, and having AIDS-related lymphoma
(ARL) in his liver and an intrahepatic bile duct obstruc-
tion 2 months ago. A liver biopsy showed B-cell type
lymphoma. He received the chemotherapy combination of
cyclophosphamide, doxorubicin, vincristine, and prednis-
one (CHOP). Magnetic resonance imaging (MRI) of his
thoracic and lumbar spine showed a 1.5×2×5cm elongated
intraspinal extramedullary mass from T2 to T4. The lesion
showed intermediate-to-high signal intensity on T2-
weighted image, intermediate-to-low signal intensity on
T1-weighted image and heterogeneous enhancement after
gadolinium-infusion (Figure 1). A computed tomography
(CT) scan showed no definite bony destruction (Figure 2),
but abnormal signal intensities and enhancement were
found from the T9 to T11 vertebral bodies. Lymphoma
was suspected. Emergent radiation therapy was performed
at the C7 to T5 field, chemotherapy was administered
preoperatively, and surgical decompression and excisional
biopsy were performed. The pathologic findings showed
that the specimen was compatible with B-UCL with
features intermediate between DLBCL and BL (Figure 3).Figure 1 Magnetic resonance image shows elongated epidural
mass at the left posterolateral aspect of the spinal cord at the T2
to T4 levels, resulting in severe cord compression. A, T2-weighted
image sagittal; B, T1-weighted image sagittal; C, T1-weighted image
enhanced sagittal; D, T2-weighted image axial; E, T1-weighted image
axial; F, T1-wighted image enhanced axial.Immunohistochemistry showed the tumor cells were
CD20-positive and CD45RO-negative. The patient received
chemotherapy and radiation therapy with highly active
antiretroviral therapy (HAART) after surgery. Radiation
treatment of 200cGy per fraction was performed (3000cGy
in 15 fractions). However, his motor power was not
improved. A postoperative abdominal CT scan at 5 weeks
showed increased lymphoma size in his liver. Moreover,
pulmonary thromboembolism and leptomeningeal seeding
were detected. A relapsed mass was found from the C5 to
T1 area on follow-up MRI. His complete blood cell count
was below the lower limit, and his deteriorating condition
did not permit additional chemotherapy. He was trans-
ferred to hospice care, and he died by massive pulmonary
thromboembolism at 13 weeks postoperatively.
Discussion
HIV infection can result in neoplasm due to damaged
cellular immunity [3,4]. Individuals infected with HIVFigure 3 The pathology findings showed that the specimen
was compatible with B-cell lymphoma unclassifiable with
features intermediate between diffuse large B-cell lymphoma
and Burkitt lymphoma. Hypercellular bone marrow was replaced
by a homogeneous population of lymphoid cells (hematoxylin-eosin
stain ×400).
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Approximately two-thirds of ARL cases are categorized
as diffuse large B-cell type, with BL comprising 25% and
other histology a much smaller proportion [5]. Recent
clinical trials have demonstrated a better outcome with
chemotherapy for ARL since the introduction of com-
bination antiretroviral treatment, termed HAART [6].
However, the treatment of lymphomas in patients infected
with HIV has been less than satisfactory, with a high mor-
tality rate [4]. The patient in this case was diagnosed with
B-UCL with features intermediate between DLBCL and
BL. These rare lymphomas, which occur predominantly in
adults, have a germinal center phenotype that resembles
BL but exhibit atypical cytological features for BL [7].
On morphological examination, cases of B-UCL have archi-
tectural and cytological features intermediate between
DLBCL and BL, and are composed of a diffuse prolifera-
tion of predominantly medium-sized, centroblast-like
cells with numerous tingible-body macrophages admixed.
Immunophenotypically, these lymphomas often have a
germinal center B-cell phenotype with positivity for CD10
and bcl6, and are frequently bcl2 positive. A case of typical
BL with strong bcl2 expression is also placed into this
category [1]. Clinically, B-UCL is generally considered to
be an aggressive lymphoma and most patients present
with widespread disease. However, there are currently no
well-established therapies for these patients. Most studies
have reported poor outcomes with the standard therapies
used for DLBCL, as well as with more intensive regimens
[1,8-11].
Extranodal involvement of lymphoma commonly in-
volves the gastrointestinal tract, bone marrow, liver, lung
and central nervous system. Although survival from
ARL has improved significantly with HAART [12], it is
associated with high mortality rates when the epidural
space is involved [13]. Epidural spinal cord compression
occurs in 0.1 to 6.5% of patients with non-Hodgkin’s
lymphoma (NHL) [14-16], either at the time of recurrence
[17] or at the initial diagnosis [18]. Lymphoma is thought
to involve the paraspinal soft tissues first, such as the
paravertebral ganglion or epidural lymphoid tissue, and
then invade around the cord via the vertebral foramen
without destroying bony structures [15,19]. It is important
to discriminate whether the paraspinal mass is a primary
lesion or secondary metastatic lesion. Molecular imaging
by positron emission tomography is helpful to diagnosis,
identification of the metabolically active tumor compart-
ment, and prediction of treatment response [20]. Surgery,
radiotherapy, or a combination of both are treatment
options for spinal cord compression by lymphoma. Chang
et al. [21] suggested that surgical decompression can
improve recovery from neurological deficits in patients
with DLBCL-associated spinal cord compression, but Peng
et al. [22] recommended nonsurgical rather than surgicaltreatment because of the high mortality rate after surgery.
In the present case, the lymphoma metastasized to the
epidural space followed by spinal cord compression. The
patient did not respond to CHOP chemotherapy and
radiation therapy. We were obliged to perform surgical
decompression in this urgent situation.
Conclusions
Spine surgeons should consider the possibility of NHL-
associated spinal cord compression in patients seropositive
for HIV who present with rapidly progressive paraplegia,
and treatment should take into account the patient’s condi-
tion in addition to the subtype and prognosis of the
lymphoma.
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